TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
UCB Pharma Oy Finland
Closing information (x1000 SEK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
172,596
|
160,191
|
167,092 |
| Financial expenses |
431
|
320
|
247 |
| Earnings before taxes |
7,539
|
4,248
|
6,090 |
| Total assets |
77,970
|
69,033
|
59,995 |
| Current assets |
11,633
|
14,296
|
3,083 |
| Current liabilities |
44,496
|
32,192
|
53,705 |
| Equity capital |
7,778
|
4,997
|
6,280 |
| - share capital |
77
|
73
|
76 |
| Employees (average) |
14
|
16
|
18 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
10.0%
|
7.2%
|
10.5% |
| Turnover per employee |
12,328
|
10,012
|
9,283 |
| Profit as a percentage of turnover |
4.4%
|
2.7%
|
3.6% |
| Return on assets (ROA) |
10.2%
|
6.6%
|
10.6% |
| Current ratio |
26.1%
|
44.4%
|
5.7% |
| Return on equity (ROE) |
96.9%
|
85.0%
|
97.0% |
| Change turnover |
4,831
|
-219
|
6,280 |
| Change turnover % |
3%
|
0%
|
4% |
| Chg. No. of employees |
-2
|
-2
|
-1 |
| Chg. No. of employees % |
-13%
|
-11%
|
-5% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.